Page last updated: 2024-11-03

pyrimethamine and Duncan Disease

pyrimethamine has been researched along with Duncan Disease in 3 studies

Maloprim: contains above 2 cpds

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rao, VK1
Dowdell, KC1
Dale, JK1
Dugan, F1
Pesnicak, L1
Bi, LL1
Hoffmann, V1
Penzak, S1
Avila, NA1
Fleisher, TA1
Puck, JM1
Straus, SE1
van der Werff ten Bosch, JE1
Demanet, C2
Balduck, N1
Bakkus, MH1
De Raeve, H1
Desprechins, B1
Otten, J2
Thielemans, K2
van der Werff Ten Bosch, J1
Schotte, P1
Ferster, A1
Azzi, N1
Boehler, T1
Laurey, G1
Arola, M1
Beyaert, R1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Pilot Study of Pyrimethamine and Sulfadoxine (Fansidar) for the Treatment of Individuals With the Autoimmune Lymphoproliferative Syndrome (ALPS)[NCT00013689]Phase 18 participants Interventional2001-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

3 other studies available for pyrimethamine and Duncan Disease

ArticleYear
Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome.
    American journal of hematology, 2007, Volume: 82, Issue:12

    Topics: Animals; Apoptosis; Autoimmune Diseases; Cell Death; Child; Humans; Infant; Infant, Newborn; Lymph N

2007
The use of the anti-malaria drug Fansidar (pyrimethamine and sulphadoxine) in the treatment of a patient with autoimmune lymphoproliferative syndrome and Fas deficiency.
    British journal of haematology, 1998, Volume: 102, Issue:2

    Topics: Antimalarials; Autoimmune Diseases; Drug Combinations; fas Receptor; Humans; Infant; Lymphoprolifera

1998
Reversion of autoimmune lymphoproliferative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observations.
    British journal of haematology, 2002, Volume: 117, Issue:1

    Topics: Adolescent; Antimalarials; Apoptosis; Autoimmune Diseases; Case-Control Studies; Caspase 3; Caspases

2002